HEADER COMPLEX (GTP-BINDING/TRANSDUCER) 07-AUG-96 1GOT TITLE HETEROTRIMERIC COMPLEX OF A GT-ALPHA/GI-ALPHA CHIMERA AND TITLE 2 THE GT-BETA-GAMMA SUBUNITS COMPND MOL_ID: 1; COMPND 2 MOLECULE: GT-ALPHA/GI-ALPHA CHIMERA; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: THIS IS A CHIMERIC PROTEIN WHERE RESIDUES COMPND 6 216-294 OF BOVINE GT ALPHA HAVE BEEN REPLACED WITH COMPND 7 RESIDUES 220-298 OF RAT GI ALPHA 1; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: GT-BETA; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: BETA1, TRANSDUCIN BETA SUBUNIT; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: GT-GAMMA; COMPND 15 CHAIN: G; COMPND 16 SYNONYM: GAMMA1, TRANSDUCIN GAMMA SUBUNIT; COMPND 17 ENGINEERED: YES; COMPND 18 OTHER_DETAILS: GT-BETA-GAMMA WAS TREATED WITH ENDOPROTEASE- COMPND 19 LYSC TO REMOVE THE THREE C-TERMINAL AMINO ACIDS AND THE COMPND 20 TERMINAL FARNESYL MOIETY OF GAMMA SOURCE MOL_ID: 1; SOURCE 2 FRAGMENT: 216 - 294; SOURCE 3 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 4 ORGANISM_COMMON: CATTLE; SOURCE 5 ORGANISM_TAXID: 9913; SOURCE 6 ORGAN: EYE; SOURCE 7 TISSUE: RETINA; SOURCE 8 CELL: ROD; SOURCE 9 ORGANELLE: ROD OUTER SEGMENT; SOURCE 10 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 11 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 12 EXPRESSION_SYSTEM_STRAIN: PET; SOURCE 13 EXPRESSION_SYSTEM_VECTOR_TYPE: PET; SOURCE 14 EXPRESSION_SYSTEM_PLASMID: PET VECTOR; SOURCE 15 OTHER_DETAILS: T7 LAC PROMOTER; SOURCE 16 MOL_ID: 2; SOURCE 17 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 18 ORGANISM_COMMON: CATTLE; SOURCE 19 ORGANISM_TAXID: 9913; SOURCE 20 ORGAN: EYE; SOURCE 21 TISSUE: RETINA; SOURCE 22 CELL: ROD; SOURCE 23 ORGANELLE: ROD OUTER SEGMENT; SOURCE 24 MOL_ID: 3; SOURCE 25 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 26 ORGANISM_COMMON: CATTLE; SOURCE 27 ORGANISM_TAXID: 9913; SOURCE 28 ORGAN: EYE; SOURCE 29 TISSUE: RETINA; SOURCE 30 CELL: ROD; SOURCE 31 ORGANELLE: ROD OUTER SEGMENT KEYWDS COMPLEX (GTP-BINDING/TRANSDUCER), G PROTEIN, HETEROTRIMER KEYWDS 2 SIGNAL TRANSDUCTION EXPDTA X-RAY DIFFRACTION AUTHOR D.G.LAMBRIGHT,J.SONDEK,A.BOHM,N.P.SKIBA,H.E.HAMM,P.B.SIGLER REVDAT 2 24-FEB-09 1GOT 1 VERSN REVDAT 1 12-MAR-97 1GOT 0 JRNL AUTH D.G.LAMBRIGHT,J.SONDEK,A.BOHM,N.P.SKIBA,H.E.HAMM, JRNL AUTH 2 P.B.SIGLER JRNL TITL THE 2.0 A CRYSTAL STRUCTURE OF A HETEROTRIMERIC G JRNL TITL 2 PROTEIN. JRNL REF NATURE V. 379 311 1996 JRNL REFN ISSN 0028-0836 JRNL PMID 8552184 JRNL DOI 10.1038/379311A0 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.SONDEK,A.BOHM,D.G.LAMBRIGHT,H.E.HAMM,P.B.SIGLER REMARK 1 TITL CRYSTAL STRUCTURE OF A GA PROTEIN BETA GAMMA DIMER REMARK 1 TITL 2 AT 2.1A RESOLUTION REMARK 1 REF NATURE V. 379 369 1996 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.G.LAMBRIGHT,J.P.NOEL,H.E.HAMM,P.B.SIGLER REMARK 1 TITL STRUCTURAL DETERMINANTS FOR ACTIVATION OF THE REMARK 1 TITL 2 ALPHA-SUBUNIT OF A HETEROTRIMERIC G PROTEIN REMARK 1 REF NATURE V. 369 621 1994 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.SONDEK,D.G.LAMBRIGHT,J.P.NOEL,H.E.HAMM,P.B.SIGLER REMARK 1 TITL GTPASE MECHANISM OF GPROTEINS FROM THE 1.7-A REMARK 1 TITL 2 CRYSTAL STRUCTURE OF TRANSDUCIN ALPHA-GDP-AIF-4 REMARK 1 REF NATURE V. 372 276 1994 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.P.NOEL,H.E.HAMM,P.B.SIGLER REMARK 1 TITL THE 2.2 A CRYSTAL STRUCTURE OF TRANSDUCIN-ALPHA REMARK 1 TITL 2 COMPLEXED WITH GTP GAMMA S REMARK 1 REF NATURE V. 366 654 1993 REMARK 1 REFN ISSN 0028-0836 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXS, X-PLOR 3.1 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.207 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.295 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5803 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 616 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 ANGLE DISTANCES (A) : NULL REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GOT COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAY-95 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54174 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: SHELXS, X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 MG/ML OF HETEROTRIMERIC COMPLEX REMARK 280 WERE MIXED 1:1 WITH WELL SOLUTION CONTAINING 10% PEG-8000, 50 REMARK 280 MM TRIS, PH 8.0, 10% GLYCEROL, 50 MM NACL, .1 MM REMARK 280 MERCAPTOETHANOL. MIXTURE EQUILIBRATED VS WELL SOLUTION IN REMARK 280 HANGING DROPS AT 4 DEGREES C., VAPOR DIFFUSION - HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 66.70000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.70000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 66.70000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 45.70000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH G 356 LIES ON A SPECIAL POSITION. REMARK 375 HOH G 357 LIES ON A SPECIAL POSITION. REMARK 450 REMARK 450 SOURCE REMARK 450 REMARK 450 GT-BETA-GAMMA WAS TREATED WITH ENDOPROTEASE-LYSC TO REMOVE REMARK 450 THE THREE C-TERMINAL AMINO ACIDS AND THE FARNESYL MOIETY OF REMARK 450 THE GAMMA SUBUNIT. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 ALA A 3 REMARK 465 GLY A 4 REMARK 465 ALA A 5 REMARK 465 LEU A 344 REMARK 465 LYS A 345 REMARK 465 ASP A 346 REMARK 465 CYS A 347 REMARK 465 GLY A 348 REMARK 465 LEU A 349 REMARK 465 PHE A 350 REMARK 465 MET B 1 REMARK 465 MET G -6 REMARK 465 PRO G -5 REMARK 465 VAL G -4 REMARK 465 ILE G -3 REMARK 465 ASN G -2 REMARK 465 ILE G -1 REMARK 465 GLU G 0 REMARK 465 ASP G 1 REMARK 465 PRO G 2 REMARK 465 VAL G 3 REMARK 465 ILE G 4 REMARK 465 ASN G 5 REMARK 465 ILE G 6 REMARK 465 GLU G 7 REMARK 465 ASP G 8 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 6 OG REMARK 470 ASN A 343 CG OD1 ND2 REMARK 470 LEU G 9 CG CD1 CD2 REMARK 470 THR G 10 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 109 -45.81 -134.99 REMARK 500 SER A 202 179.14 179.88 REMARK 500 GLU A 234 27.13 -73.75 REMARK 500 LYS A 341 43.97 -92.21 REMARK 500 GLU A 342 -21.91 -165.97 REMARK 500 ARG B 68 -46.24 -135.84 REMARK 500 TRP B 99 47.26 -85.60 REMARK 500 THR B 128 -71.20 -152.12 REMARK 500 SER B 227 -169.55 -125.32 REMARK 500 MET B 262 148.15 -173.99 REMARK 500 PHE B 292 -2.01 91.71 REMARK 500 SER B 334 1.76 81.33 REMARK 500 THR G 10 -98.56 44.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH G 374 DISTANCE = 5.03 ANGSTROMS REMARK 525 HOH A 552 DISTANCE = 6.39 ANGSTROMS REMARK 525 HOH A 681 DISTANCE = 7.47 ANGSTROMS REMARK 525 HOH A 697 DISTANCE = 6.37 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDP G 355 DBREF 1GOT A 2 350 UNP P04695 GBT1_BOVIN 1 349 DBREF 1GOT B 1 340 UNP P62871 GBB1_BOVIN 1 340 DBREF 1GOT G 2 66 UNP P02698 GBG1_BOVIN 1 65 SEQADV 1GOT MSE A 49 UNP P04695 MET 48 MODIFIED RESIDUE SEQADV 1GOT MSE A 84 UNP P04695 MET 83 MODIFIED RESIDUE SEQADV 1GOT MSE A 104 UNP P04695 MET 103 MODIFIED RESIDUE SEQADV 1GOT MSE A 106 UNP P04695 MET 105 MODIFIED RESIDUE SEQADV 1GOT MSE A 115 UNP P04695 MET 114 MODIFIED RESIDUE SEQADV 1GOT MSE A 119 UNP P04695 MET 118 MODIFIED RESIDUE SEQADV 1GOT MSE A 194 UNP P04695 MET 193 MODIFIED RESIDUE SEQADV 1GOT ALA A 216 UNP P04695 CYS 215 CONFLICT SEQADV 1GOT CYS A 220 UNP P04695 ILE 219 CONFLICT SEQADV 1GOT VAL A 221 UNP P04695 ALA 220 CONFLICT SEQADV 1GOT ASP A 225 UNP P04695 ALA 224 CONFLICT SEQADV 1GOT LEU A 228 UNP P04695 MET 227 CONFLICT SEQADV 1GOT ALA A 231 UNP P04695 VAL 230 CONFLICT SEQADV 1GOT GLU A 234 UNP P04695 ASP 233 CONFLICT SEQADV 1GOT MSE A 236 UNP P04695 VAL 235 CONFLICT SEQADV 1GOT MSE A 239 UNP P04695 MET 238 CONFLICT SEQADV 1GOT MSE A 243 UNP P04695 LEU 242 CONFLICT SEQADV 1GOT LYS A 244 UNP P04695 HIS 243 CONFLICT SEQADV 1GOT ASP A 247 UNP P04695 ASN 246 CONFLICT SEQADV 1GOT ASN A 252 UNP P04695 HIS 251 CONFLICT SEQADV 1GOT LYS A 253 UNP P04695 ARG 252 CONFLICT SEQADV 1GOT TRP A 254 UNP P04695 TYR 253 CONFLICT SEQADV 1GOT THR A 256 UNP P04695 ALA 255 CONFLICT SEQADV 1GOT ASP A 257 UNP P04695 THR 256 CONFLICT SEQADV 1GOT ILE A 261 UNP P04695 VAL 260 CONFLICT SEQADV 1GOT LEU A 269 UNP P04695 VAL 268 CONFLICT SEQADV 1GOT GLU A 271 UNP P04695 SER 270 CONFLICT SEQADV 1GOT SER A 277 UNP P04695 ALA 276 CONFLICT SEQADV 1GOT PRO A 278 UNP P04695 HIS 277 CONFLICT SEQADV 1GOT THR A 280 UNP P04695 SER 279 CONFLICT SEQADV 1GOT TYR A 283 UNP P04695 PHE 282 CONFLICT SEQADV 1GOT GLU A 285 UNP P04695 ASP 284 CONFLICT SEQADV 1GOT ALA A 287 UNP P04695 ASN 286 CONFLICT SEQADV 1GOT SER A 289 UNP P04695 PRO 288 CONFLICT SEQADV 1GOT GLU A 294 UNP P04695 ASP 293 CONFLICT SEQADV 1GOT MSE A 308 UNP P04695 MET 307 MODIFIED RESIDUE SEQADV 1GOT MSE A 319 UNP P04695 MET 318 MODIFIED RESIDUE SEQRES 1 A 350 MET GLY ALA GLY ALA SER ALA GLU GLU LYS HIS SER ARG SEQRES 2 A 350 GLU LEU GLU LYS LYS LEU LYS GLU ASP ALA GLU LYS ASP SEQRES 3 A 350 ALA ARG THR VAL LYS LEU LEU LEU LEU GLY ALA GLY GLU SEQRES 4 A 350 SER GLY LYS SER THR ILE VAL LYS GLN MSE LYS ILE ILE SEQRES 5 A 350 HIS GLN ASP GLY TYR SER LEU GLU GLU CYS LEU GLU PHE SEQRES 6 A 350 ILE ALA ILE ILE TYR GLY ASN THR LEU GLN SER ILE LEU SEQRES 7 A 350 ALA ILE VAL ARG ALA MSE THR THR LEU ASN ILE GLN TYR SEQRES 8 A 350 GLY ASP SER ALA ARG GLN ASP ASP ALA ARG LYS LEU MSE SEQRES 9 A 350 HIS MSE ALA ASP THR ILE GLU GLU GLY THR MSE PRO LYS SEQRES 10 A 350 GLU MSE SER ASP ILE ILE GLN ARG LEU TRP LYS ASP SER SEQRES 11 A 350 GLY ILE GLN ALA CYS PHE ASP ARG ALA SER GLU TYR GLN SEQRES 12 A 350 LEU ASN ASP SER ALA GLY TYR TYR LEU SER ASP LEU GLU SEQRES 13 A 350 ARG LEU VAL THR PRO GLY TYR VAL PRO THR GLU GLN ASP SEQRES 14 A 350 VAL LEU ARG SER ARG VAL LYS THR THR GLY ILE ILE GLU SEQRES 15 A 350 THR GLN PHE SER PHE LYS ASP LEU ASN PHE ARG MSE PHE SEQRES 16 A 350 ASP VAL GLY GLY GLN ARG SER GLU ARG LYS LYS TRP ILE SEQRES 17 A 350 HIS CYS PHE GLU GLY VAL THR ALA ILE ILE PHE CYS VAL SEQRES 18 A 350 ALA LEU SER ASP TYR ASP LEU VAL LEU ALA GLU ASP GLU SEQRES 19 A 350 GLU MSE ASN ARG MSE HIS GLU SER MSE LYS LEU PHE ASP SEQRES 20 A 350 SER ILE CYS ASN ASN LYS TRP PHE THR ASP THR SER ILE SEQRES 21 A 350 ILE LEU PHE LEU ASN LYS LYS ASP LEU PHE GLU GLU LYS SEQRES 22 A 350 ILE LYS LYS SER PRO LEU THR ILE CYS TYR PRO GLU TYR SEQRES 23 A 350 ALA GLY SER ASN THR TYR GLU GLU ALA GLY ASN TYR ILE SEQRES 24 A 350 LYS VAL GLN PHE LEU GLU LEU ASN MSE ARG ARG ASP VAL SEQRES 25 A 350 LYS GLU ILE TYR SER HIS MSE THR CYS ALA THR ASP THR SEQRES 26 A 350 GLN ASN VAL LYS PHE VAL PHE ASP ALA VAL THR ASP ILE SEQRES 27 A 350 ILE ILE LYS GLU ASN LEU LYS ASP CYS GLY LEU PHE SEQRES 1 B 340 MET SER GLU LEU ASP GLN LEU ARG GLN GLU ALA GLU GLN SEQRES 2 B 340 LEU LYS ASN GLN ILE ARG ASP ALA ARG LYS ALA CYS ALA SEQRES 3 B 340 ASP ALA THR LEU SER GLN ILE THR ASN ASN ILE ASP PRO SEQRES 4 B 340 VAL GLY ARG ILE GLN MET ARG THR ARG ARG THR LEU ARG SEQRES 5 B 340 GLY HIS LEU ALA LYS ILE TYR ALA MET HIS TRP GLY THR SEQRES 6 B 340 ASP SER ARG LEU LEU LEU SER ALA SER GLN ASP GLY LYS SEQRES 7 B 340 LEU ILE ILE TRP ASP SER TYR THR THR ASN LYS VAL HIS SEQRES 8 B 340 ALA ILE PRO LEU ARG SER SER TRP VAL MET THR CYS ALA SEQRES 9 B 340 TYR ALA PRO SER GLY ASN TYR VAL ALA CYS GLY GLY LEU SEQRES 10 B 340 ASP ASN ILE CYS SER ILE TYR ASN LEU LYS THR ARG GLU SEQRES 11 B 340 GLY ASN VAL ARG VAL SER ARG GLU LEU ALA GLY HIS THR SEQRES 12 B 340 GLY TYR LEU SER CYS CYS ARG PHE LEU ASP ASP ASN GLN SEQRES 13 B 340 ILE VAL THR SER SER GLY ASP THR THR CYS ALA LEU TRP SEQRES 14 B 340 ASP ILE GLU THR GLY GLN GLN THR THR THR PHE THR GLY SEQRES 15 B 340 HIS THR GLY ASP VAL MET SER LEU SER LEU ALA PRO ASP SEQRES 16 B 340 THR ARG LEU PHE VAL SER GLY ALA CYS ASP ALA SER ALA SEQRES 17 B 340 LYS LEU TRP ASP VAL ARG GLU GLY MET CYS ARG GLN THR SEQRES 18 B 340 PHE THR GLY HIS GLU SER ASP ILE ASN ALA ILE CYS PHE SEQRES 19 B 340 PHE PRO ASN GLY ASN ALA PHE ALA THR GLY SER ASP ASP SEQRES 20 B 340 ALA THR CYS ARG LEU PHE ASP LEU ARG ALA ASP GLN GLU SEQRES 21 B 340 LEU MET THR TYR SER HIS ASP ASN ILE ILE CYS GLY ILE SEQRES 22 B 340 THR SER VAL SER PHE SER LYS SER GLY ARG LEU LEU LEU SEQRES 23 B 340 ALA GLY TYR ASP ASP PHE ASN CYS ASN VAL TRP ASP ALA SEQRES 24 B 340 LEU LYS ALA ASP ARG ALA GLY VAL LEU ALA GLY HIS ASP SEQRES 25 B 340 ASN ARG VAL SER CYS LEU GLY VAL THR ASP ASP GLY MET SEQRES 26 B 340 ALA VAL ALA THR GLY SER TRP ASP SER PHE LEU LYS ILE SEQRES 27 B 340 TRP ASN SEQRES 1 G 73 MET PRO VAL ILE ASN ILE GLU ASP PRO VAL ILE ASN ILE SEQRES 2 G 73 GLU ASP LEU THR GLU LYS ASP LYS LEU LYS MET GLU VAL SEQRES 3 G 73 ASP GLN LEU LYS LYS GLU VAL THR LEU GLU ARG MET LEU SEQRES 4 G 73 VAL SER LYS CYS CYS GLU GLU PHE ARG ASP TYR VAL GLU SEQRES 5 G 73 GLU ARG SER GLY GLU ASP PRO LEU VAL LYS GLY ILE PRO SEQRES 6 G 73 GLU ASP LYS ASN PRO PHE LYS GLU MODRES 1GOT MSE A 49 MET SELENOMETHIONINE MODRES 1GOT MSE A 84 MET SELENOMETHIONINE MODRES 1GOT MSE A 104 MET SELENOMETHIONINE MODRES 1GOT MSE A 106 MET SELENOMETHIONINE MODRES 1GOT MSE A 115 MET SELENOMETHIONINE MODRES 1GOT MSE A 119 MET SELENOMETHIONINE MODRES 1GOT MSE A 194 MET SELENOMETHIONINE MODRES 1GOT MSE A 236 MET SELENOMETHIONINE MODRES 1GOT MSE A 239 MET SELENOMETHIONINE MODRES 1GOT MSE A 243 MET SELENOMETHIONINE MODRES 1GOT MSE A 308 MET SELENOMETHIONINE MODRES 1GOT MSE A 319 MET SELENOMETHIONINE HET MSE A 49 8 HET MSE A 84 8 HET MSE A 104 8 HET MSE A 106 8 HET MSE A 115 8 HET MSE A 119 8 HET MSE A 194 8 HET MSE A 236 8 HET MSE A 239 8 HET MSE A 243 8 HET MSE A 308 8 HET MSE A 319 8 HET GDP G 355 28 HETNAM MSE SELENOMETHIONINE HETNAM GDP GUANOSINE-5'-DIPHOSPHATE FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 4 GDP C10 H15 N5 O11 P2 FORMUL 5 HOH *616(H2 O) HELIX 1 1 ALA A 7 ARG A 28 1 22 HELIX 2 2 LYS A 42 HIS A 53 1 12 HELIX 3 3 LEU A 59 THR A 86 1 28 HELIX 4 4 SER A 94 ASP A 108 5 15 HELIX 5 5 LYS A 117 LYS A 128 1 12 HELIX 6 6 SER A 130 GLU A 141 1 12 HELIX 7 7 ALA A 148 VAL A 159 1 12 HELIX 8 8 GLU A 167 LEU A 171 1 5 HELIX 9 9 ARG A 204 LYS A 206 5 3 HELIX 10 10 ILE A 208 PHE A 211 5 4 HELIX 11 11 LEU A 223 ASP A 227 5 5 HELIX 12 12 ARG A 238 CYS A 250 1 13 HELIX 13 13 LYS A 253 PHE A 255 5 3 HELIX 14 14 LYS A 267 LYS A 275 1 9 HELIX 15 15 LEU A 279 ILE A 281 5 3 HELIX 16 16 TYR A 292 LEU A 306 1 15 HELIX 17 17 THR A 325 ILE A 340 1 16 HELIX 18 18 GLU B 3 CYS B 25 1 23 HELIX 19 19 LEU B 30 ILE B 33 1 4 HELIX 20 20 GLU G 11 THR G 27 1 17 HELIX 21 21 VAL G 33 GLU G 50 1 18 HELIX 22 22 PRO G 52 LYS G 55 1 4 HELIX 23 23 GLU G 59 LYS G 61 5 3 SHEET 1 A 6 TYR A 316 MSE A 319 0 SHEET 2 A 6 SER A 259 ASN A 265 1 N LEU A 262 O TYR A 316 SHEET 3 A 6 ALA A 216 ALA A 222 1 N ILE A 217 O SER A 259 SHEET 4 A 6 THR A 29 GLY A 36 1 N LEU A 33 O ALA A 216 SHEET 5 A 6 LEU A 190 ASP A 196 1 N ASN A 191 O VAL A 30 SHEET 6 A 6 ILE A 181 PHE A 187 -1 N PHE A 187 O LEU A 190 SHEET 1 B 4 ILE B 58 TRP B 63 0 SHEET 2 B 4 LEU B 69 SER B 74 -1 N ALA B 73 O TYR B 59 SHEET 3 B 4 LYS B 78 ASP B 83 -1 N TRP B 82 O LEU B 70 SHEET 4 B 4 LYS B 89 PRO B 94 -1 N ILE B 93 O LEU B 79 SHEET 1 C 4 VAL B 100 TYR B 105 0 SHEET 2 C 4 TYR B 111 GLY B 116 -1 N GLY B 115 O MET B 101 SHEET 3 C 4 ILE B 120 ASN B 125 -1 N TYR B 124 O VAL B 112 SHEET 4 C 4 ARG B 134 ALA B 140 -1 N LEU B 139 O CYS B 121 SHEET 1 D 4 LEU B 146 PHE B 151 0 SHEET 2 D 4 GLN B 156 SER B 161 -1 N SER B 160 O SER B 147 SHEET 3 D 4 CYS B 166 ASP B 170 -1 N TRP B 169 O ILE B 157 SHEET 4 D 4 GLN B 175 PHE B 180 -1 N PHE B 180 O CYS B 166 SHEET 1 E 4 VAL B 187 LEU B 192 0 SHEET 2 E 4 LEU B 198 ALA B 203 -1 N GLY B 202 O MET B 188 SHEET 3 E 4 ALA B 208 ASP B 212 -1 N TRP B 211 O PHE B 199 SHEET 4 E 4 CYS B 218 PHE B 222 -1 N PHE B 222 O ALA B 208 SHEET 1 F 4 ILE B 229 PHE B 234 0 SHEET 2 F 4 ALA B 240 SER B 245 -1 N GLY B 244 O ASN B 230 SHEET 3 F 4 CYS B 250 ASP B 254 -1 N PHE B 253 O PHE B 241 SHEET 4 F 4 GLN B 259 TYR B 264 -1 N TYR B 264 O CYS B 250 SHEET 1 G 4 ILE B 273 PHE B 278 0 SHEET 2 G 4 LEU B 284 TYR B 289 -1 N GLY B 288 O THR B 274 SHEET 3 G 4 ASN B 293 ASP B 298 -1 N TRP B 297 O LEU B 285 SHEET 4 G 4 ARG B 304 ALA B 309 -1 N LEU B 308 O CYS B 294 SHEET 1 H 4 THR B 47 LEU B 51 0 SHEET 2 H 4 LEU B 336 TRP B 339 -1 N ILE B 338 O ARG B 48 SHEET 3 H 4 VAL B 327 SER B 331 -1 N THR B 329 O LYS B 337 SHEET 4 H 4 VAL B 315 VAL B 320 -1 N GLY B 319 O ALA B 328 LINK N MSE A 49 C GLN A 48 1555 1555 1.33 LINK C MSE A 49 N LYS A 50 1555 1555 1.33 LINK N MSE A 84 C ALA A 83 1555 1555 1.34 LINK C MSE A 84 N THR A 85 1555 1555 1.33 LINK N MSE A 104 C LEU A 103 1555 1555 1.33 LINK C MSE A 104 N HIS A 105 1555 1555 1.33 LINK N MSE A 106 C HIS A 105 1555 1555 1.33 LINK C MSE A 106 N ALA A 107 1555 1555 1.33 LINK N MSE A 115 C THR A 114 1555 1555 1.33 LINK C MSE A 115 N PRO A 116 1555 1555 1.35 LINK N MSE A 119 C GLU A 118 1555 1555 1.33 LINK C MSE A 119 N SER A 120 1555 1555 1.33 LINK N MSE A 194 C ARG A 193 1555 1555 1.34 LINK C MSE A 194 N PHE A 195 1555 1555 1.33 LINK N MSE A 236 C GLU A 235 1555 1555 1.33 LINK C MSE A 236 N ASN A 237 1555 1555 1.33 LINK N MSE A 239 C ARG A 238 1555 1555 1.32 LINK C MSE A 239 N HIS A 240 1555 1555 1.33 LINK N MSE A 243 C SER A 242 1555 1555 1.33 LINK C MSE A 243 N LYS A 244 1555 1555 1.33 LINK N MSE A 308 C ASN A 307 1555 1555 1.34 LINK C MSE A 308 N ARG A 309 1555 1555 1.33 LINK N MSE A 319 C HIS A 318 1555 1555 1.33 LINK C MSE A 319 N THR A 320 1555 1555 1.33 SITE 1 AC1 24 GLY A 38 GLU A 39 SER A 40 GLY A 41 SITE 2 AC1 24 LYS A 42 SER A 43 THR A 44 ASP A 146 SITE 3 AC1 24 SER A 147 LEU A 171 ARG A 172 ARG A 174 SITE 4 AC1 24 ASN A 265 LYS A 266 ASP A 268 LEU A 269 SITE 5 AC1 24 CYS A 321 ALA A 322 THR A 323 HOH A 369 SITE 6 AC1 24 HOH A 563 HOH G 358 HOH G 359 HOH G 367 CRYST1 133.400 91.400 83.200 90.00 120.10 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007496 0.000000 0.004345 0.00000 SCALE2 0.000000 0.010941 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013893 0.00000